Fecal microbiota transplantation for induction of remission in Crohn’s disease: a systematic review and meta-analysis (original) (raw)

References

  1. Baumgart DC, Sandborn WJ (2012) Crohn’s disease. Lancet 380:1590–1605. https://doi.org/10.1016/S0140-6736(12)60026-9
    Article PubMed Google Scholar
  2. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre J-P (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8:244–250. https://doi.org/10.1097/00054725-200207000-00002
    Article PubMed Google Scholar
  3. Chu H, Khosravi A, Kusumawardhani IP, Kwon AHK, Vasconcelos AC, Cunha LD, Mayer AE, Shen Y, Wu W-L, Kambal A, Targan SR, Xavier RJ, Ernst PB, Green DR, McGovern DPB, Virgin HW, Mazmanian SK (2016) Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science 352:1116–1120. https://doi.org/10.1126/science.aad9948
    Article CAS PubMed PubMed Central Google Scholar
  4. Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser HJ, Reinker S, Vatanen T, Hall AB, Mallick H, McIver LJ, Sauk JS, Wilson RG, Stevens BW, Scott JM, Pierce K, Deik AA, Bullock K, Imhann F, Porter JA, Zhernakova A, Fu J, Weersma RK, Wijmenga C, Clish CB, Vlamakis H, Huttenhower C, Xavier RJ (2019) Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol 4:293–305. https://doi.org/10.1038/s41564-018-0306-4
    Article CAS PubMed Google Scholar
  5. Vaughn BP, Vatanen T, Allegretti JR, Bai A, Xavier RJ, Korzenik J, Gevers D, Ting A, Robson SC, Moss AC (2016) Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn’s disease. Inflamm Bowel Dis 22:2182–2190. https://doi.org/10.1097/mib.0000000000000893
    Article PubMed Google Scholar
  6. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104:13780–13785. https://doi.org/10.1073/pnas.0706625104
    Article CAS PubMed PubMed Central Google Scholar
  7. Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, Martinez X, Varela E, Sarrabayrouse G, Machiels K, Vermeire S, Sokol H, Guarner F, Manichanh C (2017) A microbial signature for Crohn’s disease. Gut 66:813–822. https://doi.org/10.1136/gutjnl-2016-313235
    Article CAS PubMed Google Scholar
  8. Cheng F, Huang Z, Wei W, Li Z (2021) Fecal microbiota transplantation for Crohn’s disease: a systematic review and meta-analysis. Tech Coloproctol 25:495–504. https://doi.org/10.1007/s10151-020-02395-3
    Article CAS PubMed Google Scholar
  9. Li Q, Ding X, Liu Y, Marcella C, Dai M, Zhang T, Bai J, Xiang L, Wen Q, Cui B, Zhang F (2021) Fecal microbiota transplantation is a promising switch therapy for patients with prior failure of infliximab in Crohn’s disease. Front Pharmacol 12:658087. https://doi.org/10.3389/fphar.2021.658087
  10. Guo X, Huang C, Xu J, Xu H, Liu L, Zhao H, Wang J, Huang W, Peng W, Chen Y, Nie Y, Zhou Y, Zhou Y (2021) Gut microbiota is a potential biomarker in inflammatory bowel disease. Front Nutr 8:818902. https://doi.org/10.3389/fnut.2021.818902
  11. Osaki H, Jodai Y, Koyama K, Omori T, Horiguchi N, Kamano T, Funasaka K, Nagasaka M, Nakagawa Y, Shibata T, Ohmiya N (2021) Clinical response and changes in the fecal microbiota and metabolite levels after fecal microbiota transplantation in patients with inflammatory bowel disease and recurrent infection. Fujita Med J 7:87–98. https://doi.org/10.20407/fmj.2020-021
  12. Vermeire S, Joossens M, Verbeke K, Hildebrand F, Machiels K, Van den Broeck K, Van Assche G, Rutgeerts PJ, Raes J (2012) Pilot study on the safety and efficacy of faecal microbiota transplantation in refractory Crohn’s disease. Gastroenterology 142:S360–S360
    Article Google Scholar
  13. Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, Sokol H, Arkkila P, Pintus C, Hart A, Segal J, Aloi M, Masucci L, Molinaro A, Scaldaferri F, Gasbarrini G, Lopez-Sanroman A, Link A, de Groot P, de Vos WM, Högenauer C, Malfertheiner P, Mattila E, Milosavljević T, Nieuwdorp M, Sanguinetti M, Simren M, Gasbarrini A (2017) European consensus conference on faecal microbiota transplantation in clinical practice. Gut 66:569–580. https://doi.org/10.1136/gutjnl-2016-313017
    Article PubMed Google Scholar
  14. El Hage CN, Ghoneim S, Shah S, Chahine A, Mourad FH, Francis FF, Binion DG, Farraye FA, Hashash JG (2022) Efficacy of fecal microbiota transplantation in the treatment of active ulcerative colitis: a systematic review and meta-analysis of double-blind randomized controlled trials. Inflamm Bowel Dis. https://doi.org/10.1093/ibd/izac135
    Article Google Scholar
  15. Paramsothy S, Paramsothy R, Rubin DT, Kamm MA, Kaakoush NO, Mitchell HM, Castaño-Rodríguez N (2017) Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 11:1180–1199. https://doi.org/10.1093/ecco-jcc/jjx063
    Article PubMed Google Scholar
  16. Caldeira LdF, Borba HH, Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R (2020) Fecal microbiota transplantation in inflammatory bowel disease patients: a systematic review and meta-analysis. PLoS One 15:e0238910. https://doi.org/10.1371/journal.pone.0238910
  17. Colman RJ, Rubin DT (2014) Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 8:1569–1581. https://doi.org/10.1016/j.crohns.2014.08.006
    Article PubMed Google Scholar
  18. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71
  19. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928
  20. Suskind DL, Brittnacher MJ, Wahbeh G, Shaffer ML, Hayden HS, Qin X, Singh N, Damman CJ, Hager KR, Nielson H, Miller SI (2015) Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn’s disease. Inflamm Bowel Dis 21:556–563. https://doi.org/10.1097/MIB.0000000000000307
    Article PubMed Google Scholar
  21. Gutin L, Piceno Y, Fadrosh D, Lynch K, Zydek M, Kassam Z, LaMere B, Terdiman J, Ma A, Somsouk M, Lynch S, El-Nachef N (2019) Fecal microbiota transplant for Crohn disease: a study evaluating safety, efficacy, and microbiome profile. United European Gastroenterol J 7:807–814. https://doi.org/10.1177/2050640619845986
    Article PubMed PubMed Central Google Scholar
  22. Xiang L, Ding X, Li Q, Wu X, Dai M, Long C, He Z, Cui B, Zhang F (2020) Efficacy of faecal microbiota transplantation in Crohn’s disease: a new target treatment? Microb Biotechnol 13:760–769. https://doi.org/10.1111/1751-7915.13536
    Article PubMed PubMed Central Google Scholar
  23. Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558. https://doi.org/10.1002/sim.1186
    Article PubMed Google Scholar
  24. Vermeire S, Joossens M, Verbeke K, Wang J, Machiels K, Sabino J, Ferrante M, Van Assche G, Rutgeerts P, Raes J (2016) Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease. J Crohns Colitis 10:387–394. https://doi.org/10.1093/ecco-jcc/jjv203
    Article PubMed Google Scholar
  25. Wei Y, Zhu W, Gong J, Guo D, Gu L, Li N, Li J (2015) Fecal microbiota transplantation improves the quality of life in patients with inflammatory bowel disease. Gastroenterol Res Pract 2015:517597. https://doi.org/10.1155/2015/517597
  26. Goyal A, Yeh A, Bush BR, Firek BA, Siebold LM, Rogers MB, Kufen AD, Morowitz MJ (2018) Safety, clinical response, and microbiome findings following fecal microbiota transplant in children with inflammatory bowel disease. Inflamm Bowel Dis 24:410–421. https://doi.org/10.1093/ibd/izx035
    Article PubMed Google Scholar
  27. Yang Z, Bu C, Yuan W, Shen Z, Quan Y, Wu S, Zhu C, Wang X (2020) Fecal microbiota transplant via endoscopic delivering through small intestine and colon: no difference for Crohn’s disease. Dig Dis Sci 65:150–157. https://doi.org/10.1007/s10620-019-05751-y
    Article PubMed Google Scholar
  28. Wang H, Cui B, Li Q, Ding X, Li P, Zhang T, Yang X, Ji G, Zhang F (2018) The safety of fecal microbiota transplantation for Crohn’s disease: findings from a long-term study. Adv Ther 35:1935–1944. https://doi.org/10.1007/s12325-018-0800-3
    Article PubMed PubMed Central Google Scholar
  29. Karolewska-Bochenek K, Grzesiowski P, Banaszkiewicz A, Gawronska A, Kotowska M, Dziekiewicz M, Albrecht P, Radzikowski A, Lazowska-Przeorek I (2018) A two-week fecal microbiota transplantation course in pediatric patients with inflammatory bowel disease. Adv Exp Med Biol 1047:81–87. https://doi.org/10.1007/5584_2017_123
    Article CAS PubMed Google Scholar
  30. Li N, Tian H, Ma C, Ding C, Ge X, Gu L, Zhang X, Yang B, Hua Y, Zhu Y, Zhou Y (2017) Efficacy analysis of fecal microbiota transplantation in the treatment of 406 cases with gastrointestinal disorders. Zhonghua Wei Chang Wai Ke Za Zhi 20:40–46
    CAS PubMed Google Scholar
  31. He Z, Li P, Zhu J, Cui B, Xu L, Xiang J, Zhang T, Long C, Huang G, Ji G, Nie Y, Wu K, Fan D, Zhang F (2017) Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn’s disease complicated with inflammatory mass. Sci Rep 7:4753. https://doi.org/10.1038/s41598-017-04984-z
    Article CAS PubMed PubMed Central Google Scholar
  32. Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, Huang G, Liu Z, Wu P, Fan Z, Ji G, Wang X, Wu K, Fan D, Zhang F (2015) Fecal microbiota transplantation through mid-gut for refractory Crohn’s disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol 30:51–58. https://doi.org/10.1111/jgh.12727
    Article CAS PubMed Google Scholar
  33. Zou M, Jie Z, Cui B, Wang H, Feng Q, Zou Y, Zhang X, Yang H, Wang J, Zhang F, Jia H (2020) Fecal microbiota transplantation results in bacterial strain displacement in patients with inflammatory bowel diseases. FEBS Open Bio 10:41–55. https://doi.org/10.1002/2211-5463.12744
    Article CAS PubMed Google Scholar
  34. Takahashi K, Nishida A, Fujimoto T, Fujii M, Shioya M, Imaeda H, Inatomi O, Bamba S, Sugimoto M, Andoh A (2016) Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn’s disease. Digestion 93:59–65. https://doi.org/10.1159/000441768
    Article CAS PubMed Google Scholar
  35. Yu Y, Yang W, Li Y, Cong Y (2020) Enteroendocrine cells: sensing gut microbiota and regulating inflammatory bowel diseases. Inflamm Bowel Dis 26:11–20. https://doi.org/10.1093/ibd/izz217
    Article PubMed Google Scholar
  36. Kao D, Hotte N, Gillevet P, Madsen K (2014) Fecal microbiota transplantation inducing remission in Crohn’s colitis and the associated changes in fecal microbial profile. J Clin Gastroenterol 48:625–628. https://doi.org/10.1097/MCG.0000000000000131
    Article PubMed Google Scholar
  37. Sokol H, Landman C, Seksik P, Berard L, Montil M, Nion-Larmurier I, Bourrier A, Le Gall G, Lalande V, De Rougemont A, Kirchgesner J, Daguenel A, Cachanado M, Rousseau A, Drouet É, Rosenzwajg M, Hagege H, Dray X, Klatzman D, Marteau P, Beaugerie L, Simon T (2020) Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study. Microbiome 8:12. https://doi.org/10.1186/s40168-020-0792-5
    Article CAS PubMed PubMed Central Google Scholar
  38. Park J, Kim M, Kang SG, Jannasch AH, Cooper B, Patterson J, Kim CH (2015) Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol 8:80–93. https://doi.org/10.1038/mi.2014.44
    Article CAS PubMed Google Scholar
  39. Costello S, Waters O, Bryant R, Katsikeros R, Makanyanga J, Schoeman M, Mountifield R, Tee D, Howell S, Hughes P, Conlon M, Roberts-Thomson I, Andrews J (2017) Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial. J Crohns Colitis 11:S23–S23
    Article Google Scholar
  40. Rossen NG, Fuentes S, van der Spek MJ, Tijssen JG, Hartman JHA, Duflou A, Löwenberg M, van den Brink GR, Mathus-Vliegen EMH, de Vos WM, Zoetendal EG, D'Haens GR, Ponsioen CY (2015) Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 149. https://doi.org/10.1053/j.gastro.2015.03.045
  41. Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, Armstrong D, Marshall JK, Kassam Z, Reinisch W, Lee CH (2015) Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149. https://doi.org/10.1053/j.gastro.2015.04.001
  42. Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, Leong RWL, Connor S, Ng W, Paramsothy R, Xuan W, Lin E, Mitchell HM, Borody TJ (2017) Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389:1218–1228. https://doi.org/10.1016/S0140-6736(17)30182-4
    Article PubMed Google Scholar
  43. Varela E, Manichanh C, Gallart M, Torrejón A, Borruel N, Casellas F, Guarner F, Antolin M (2013) Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis. Aliment Pharmacol Ther 38:151–161. https://doi.org/10.1111/apt.12365
    Article CAS PubMed Google Scholar
  44. Jacob V, Crawford C, Cohen-Mekelburg S, Viladomiu M, Putzel GG, Schneider Y, Chabouni F, OʼNeil S, Bosworth B, Woo V, Ajami NJ, Petrosino JF, Gerardin Y, Kassam Z, Smith M, Iliev ID, Sonnenberg GF, Artis D, Scherl E, Longman RS (2017) Single delivery of high-diversity fecal microbiota preparation by colonoscopy is safe and effective in increasing microbial diversity in active ulcerative colitis. Inflamm Bowel Dis 23:903–911. https://doi.org/10.1097/MIB.0000000000001132
    Article PubMed Google Scholar
  45. Levy AN, Allegretti JR (2019) Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease. Therap Adv Gastroenterol 12:1756284819836893. https://doi.org/10.1177/1756284819836893
    Article PubMed PubMed Central Google Scholar
  46. Bahl MI, Bergström A, Licht TR (2012) Freezing fecal samples prior to DNA extraction affects the Firmicutes to Bacteroidetes ratio determined by downstream quantitative PCR analysis. FEMS Microbiol Lett 329:193–197. https://doi.org/10.1111/j.1574-6968.2012.02523.x
    Article CAS PubMed Google Scholar
  47. Cammarota G, Ianiro G, Gasbarrini A (2014) Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol 48:693–702. https://doi.org/10.1097/MCG.0000000000000046
    Article PubMed Google Scholar
  48. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A (2012) Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 107:761–767. https://doi.org/10.1038/ajg.2011.482
    Article PubMed Google Scholar
  49. Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL (2014) Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 312:1772–1778. https://doi.org/10.1001/jama.2014.13875
    Article CAS PubMed Google Scholar
  50. Gough E, Shaikh H, Manges AR (2011) Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53:994–1002. https://doi.org/10.1093/cid/cir632
    Article PubMed Google Scholar
  51. Haifer C, Paramsothy S, Kaakoush NO, Saikal A, Ghaly S, Yang T, Luu LDW, Borody TJ, Leong RW (2022) Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol 7:141–151. https://doi.org/10.1016/S2468-1253(21)00400-3
    Article PubMed Google Scholar
  52. Kassam Z, Lee CH, Yuan Y, Hunt RH (2013) Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 108:500–508. https://doi.org/10.1038/ajg.2013.59
    Article PubMed Google Scholar
  53. Ianiro G, Maida M, Burisch J, Simonelli C, Hold G, Ventimiglia M, Gasbarrini A, Cammarota G (2018) Efficacy of different faecal microbiota transplantation protocols for infection: a systematic review and meta-analysis. United European Gastroenterol J 6:1232–1244. https://doi.org/10.1177/2050640618780762
    Article PubMed PubMed Central Google Scholar
  54. Hui W, Li T, Liu W, Zhou C, Gao F (2019) Fecal microbiota transplantation for treatment of recurrent C. difficile infection: an updated randomized controlled trial meta-analysis. PLoS One 14:e0210016. https://doi.org/10.1371/journal.pone.0210016
  55. Costello SP, Hughes PA, Waters O, Bryant RV, Vincent AD, Blatchford P, Katsikeros R, Makanyanga J, Campaniello MA, Mavrangelos C, Rosewarne CP, Bickley C, Peters C, Schoeman MN, Conlon MA, Roberts-Thomson IC, Andrews JM (2019) Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA 321:156–164. https://doi.org/10.1001/jama.2018.20046
    Article PubMed PubMed Central Google Scholar
  56. Pai N, Popov J, Hill L, Hartung E, Grzywacz K, Moayyedi P (2021) Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects. Gastroenterology 161. https://doi.org/10.1053/j.gastro.2021.04.067
  57. Hedin C, van der Gast CJ, Rogers GB, Cuthbertson L, McCartney S, Stagg AJ, Lindsay JO, Whelan K (2016) Siblings of patients with Crohn’s disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities. Gut 65:944–953. https://doi.org/10.1136/gutjnl-2014-308896
    Article CAS PubMed Google Scholar
  58. Hoffmann DE, Palumbo FB, Ravel J, Rowthorn V, von Rosenvinge E (2017) A proposed definition of microbiota transplantation for regulatory purposes. Gut Microbes 8:208–213. https://doi.org/10.1080/19490976.2017.1293223
    Article PubMed PubMed Central Google Scholar
  59. Zhang T, Lu G, Zhao Z, Liu Y, Shen Q, Li P, Chen Y, Yin H, Wang H, Marcella C, Cui B, Cheng L, Ji G, Zhang F (2020) Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein Cell 11:251–266. https://doi.org/10.1007/s13238-019-00684-8
    Article PubMed PubMed Central Google Scholar

Download references